Site icon Eminence Papers

Pharmaceutical Management for Anxiety, Insomnia, and Depression

Pharmaceutical Management for Anxiety, Insomnia, and Depression

A 22-year-old female presenting with generalized anxiety disorder (GAD) is prescribed sertraline 25 mg orally once daily for one week, increased to 50 mg daily. Dispense #30 tablets with one refill. Sertraline, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels and reduces anxiety symptoms with favorable tolerability in young adults. Evidence supports sertraline’s effectiveness in decreasing excessive worry, restlessness, and muscle tension: Pharmaceutical Management for Anxiety, Insomnia, and Depression.

For non-prescription support, magnesium glycinate 200 mg once daily may enhance relaxation. Having access to mindfulness exercises and support groups or online counseling is an essential part of caring for someone with mental illness. It is particularly important to keep an eye out for possible suicidal thoughts in patients under 25 during the first few weeks of treatment (Singh & Saadabadi, 2023).

A 56-year-old female with chronic insomnia is prescribed trazodone 50 mg orally at bedtime as needed. Dispense #30 tablets, no refills. Trazodone, a serotonin antagonist and reuptake inhibitor (SARI), improves sleep latency and duration without increasing the risk of dependence. For additional support, melatonin 3 mg may be taken at bedtime to help realign sleep cycles.

Compassionate care includes counseling on stress management, minimizing caffeine intake, and maintaining consistent sleep routines. A critical safety point is educating the patient about orthostatic hypotension and advising her to get up slowly from bed to avoid falls (Shin & Saadabadi, 2024).

A 65-year-old male diagnosed with major depressive disorder with melancholic features is prescribed venlafaxine extended-release 37.5 mg orally once daily for one week, then increased to 75 mg daily. Dispense #30 capsules with two refills. Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), is effective for melancholic depression by enhancing mood and motivation.

Omega-3s (EPA/DHA) 1000 mg daily might help improve memory and mood. To show kindness, patients should be encouraged to exercise and have weekly meetings set up to prevent social isolation. Older individuals should have their blood pressure checked often since taking venlafaxine may raise their risk of high blood pressure (Singh & Saadabadi, 2024).

References

Shin, J. J., & Saadabadi, A. (2024, February 29). Trazodone. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470560/

Singh, D., & Saadabadi, A. (2024, February 26). Venlafaxine. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK535363/

Singh, H. K., & Saadabadi, A. (2023, February 13). Sertraline. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK547689/

ORDER A PLAGIARISM-FREE PAPER HERE

We’ll write everything from scratch

Question 


Create a pharmaceutical treatment regimen for each of the following.

Directions:

  • The patient specific details are yours to develop and consider to support your choices.
  • The non-prescription medications details if any, AND the prescription details must be present.
  • For each drug name, dose, route, frequency of administration and the prescription medications quantity to dispense must be present.
  • Include the drug class details.

    Pharmaceutical Management for Anxiety, Insomnia, and Depression

    Pharmaceutical Management for Anxiety, Insomnia, and Depression

  • Justify your decision.
  • Consider aspects of compassionate care in your response
  • Finally address a key safety point to reduce risks.

Notes:

  • Provide 3 evidence based references for your stance using standard APA format.
  • cite after every paragraph
  • No AI Use At All
Exit mobile version